$HCWB

4 stories mentioning HCWBUpdated just now

Every FINWIRES story that references HCWB, newest first.

HCW Biologics Receives US Patent Allowance for HCW9302 in Alopecia Areata

HCW Biologics (HCWB) has received a Notice of Allowance from the US Patent and Trademark Office for claims covering the use of HCW9302 to treat alopecia areata, the company said Wednesday.The allowance adds to four recently issued US patents covering HCW9302 compositions, nucleic acids and vectors, as well as methods of treating other autoimmune diseases, HCW Biologics said.HCW9302 is an IL-2-based immunotherapeutic for the treatment of autoimmune diseases through the expansion and activation of regulatory T cells, the company said.Shares of HCW Biologics were 3.5% higher in Wednesday premarket activity.

$HCWB

Wire35d ago

HCW Biologics Prices $1.6 Million Private Placement Offering

HCW Biologics (HCWB) said Wednesday it has priced an offering of 618,682 units to a group of investors, including officers, directors and an existing stockholder, to raise $1.6 million.Each unit consists of one share, or, in lieu thereof, one pre-funded warrant to buy one share, and the right to receive one warrant to purchase one share, the firm said. The price for each unit with one share and the right for one warrant was $2.585 per unit.HCW said it plans to use the net proceeds for clinical trials and for general corporate purposes.Price: $2.44, Change: $-0.15, Percent Change: -5.61%

$HCWB

Wire63d ago

HCW Biologics to Implement 1-for-6 Reverse Stock Split

HCW Biologics (HCWB) plans to implement a 1-for-6 reverse stock split on Tuesday to ensure long-term compliance with Nasdaq's minimum bid price requirement for continued listing, the company said the same day.Nasdaq found that the company has regained compliance with the listing rule on Monday, but HCW will remain subject to a mandatory monitoring period through June 17, 2027, according to the statement.Shares of HCW Biologics were down more than 5% around midday Tuesday.Price: $4.99, Change: $-0.27, Percent Change: -5.06%

$HCWB

Wire86d ago

HCW Biologics Registers Resale of Up to 5.7 Million Shares

HCW Biologics (HCWB) said Monday it is registering for the resale of up to 5.7 million common shares by selling stockholders connected to a May private placement.The shares include 427,046 already issued shares, 2.4 million shares tied to pre-funded warrants and 2.8 million shares tied to common stock purchase warrants, the company said.The May private placement sold 2.8 million units at $1.405 each and raised about $4 million in gross proceeds, the company added.HCW Biologics said it will not receive proceeds from the resale, though it may receive up to about $3.6 million if the common warrants are exercised for cash.The company added any warrant exercise proceeds would be used for general corporate purposes, including clinical and preclinical programs, research and development, working capital and other needs.Shares of the company were down more than 7% in Monday trading.Price: $1.50, Change: $-0.13, Percent Change: -7.98%

$HCWB

Track with the FINWIRES app suite

FolioX

Track HCWB in your portfolio

WheelAI

Analyze HCWB options with the wheel strategy

StockInsider

See market sentiment on HCWB